Question: What is the outlook for Neuroleptic Malignant Syndrome ?
Answer: Early identification of and treatment for individuals with neuroleptic malignant syndrome improves outcome. If clinically indicated, a low potency neuroleptic can be reintroduced very slowly when the individual recovers, although there is a risk that the syndrome might recur. Another alternative is to substitute another class of drugs for the neuroleptic. Anesthesia may be a risk to individuals who have experienced neuroleptic malignant syndrome.
Source: NINDS

Question: what research (or clinical trials) is being done for Neuroleptic Malignant Syndrome ?
Answer: The NINDS supports research on neurological disorders such as neuroleptic malignant syndrome. Much of this research focuses on finding ways to prevent and treat the disorder.
Source: NINDS